Boehringer Ingelheim, Eli Lilly sales and marketing update

Eli Lilly and Boehringer launched Abasaglar insulin glargine in the U.K. to treat Type I and Type II diabetes. Abasaglar is a biosimilar of Lantus from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France)...